Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
Add more filters










Publication year range
1.
Ann Oncol ; 28(2): 254-269, 2017 02 01.
Article in English | MEDLINE | ID: mdl-28426098

ABSTRACT

Background: Although the role of epigenetic abnormalities has been studied for several years in cancer genesis and development, epigenetic-targeting drugs have historically failed to demonstrate efficacy in solid malignancies. However, successful targeting of chromatin remodeling deficiencies, histone writers and histone reader alterations has been achieved very recently using biomarker-driven and mechanism-based approaches. Epigenetic targeting is now one of the most active areas in drug development and could represent novel therapeutic opportunity for up to 25% of all solid tumors. Material and methods: We reviewed preclinical and clinical studies that described epigenetic oncogenic addictions, synthetic lethal relationships or epigenetic antagonisms in chromatin regulators. Experimental approaches, their clinical relevance and applicability, as well as corresponding on-going studies are described. Results: The most successful approaches that have been clinically validated so far include the targeting of the BRD4-NUT fusion transcript in NUT-midline carcinoma by BET (Bromodomain Extra-Terminal) inhibitors, and the use of EZH2 (Enhancer of Zest Homolog 2) inhibitors in SMARCB1-deficient malignant rhabdoid tumors and SMARCA4-deficient ovarian small cell carcinomas. Clinical validation is still required for other synthetic lethal relationships or epigenetic antagonisms, including those described between EZH2 inhibitors and deficiencies in components of the Polycomb or SWI/SNF chromatin-remodeling complexes (including BAP1, ARID1A and PBRM1 subunits), as well as between the CREBBP and EP300 histone acetylases. Further, interplays between epigenetic modifiers and non-epigenetic cellular processes might be therapeutically exploited, and combinatorial strategies could be envisioned to overcome resistance or to sensitize cells to already approved drugs. Conclusion: Epigenetic-targeting drugs have historically failed proving efficacy in solid malignancies when used broadly, but novel mechanism-based approaches in molecularly selected patient populations have facilitated recent successes in proof-of-concept studies in solid tumors. Appropriate clinical trial design and molecular patient selection will be key for the success of epigenetic modifiers in solid tumours.


Subject(s)
Epigenesis, Genetic/drug effects , Neoplasms/drug therapy , Chromatin/genetics , Chromatin Assembly and Disassembly , Gene Expression Regulation, Neoplastic , Humans , Molecular Targeted Therapy , Neoplasms/genetics , Oncogene Addiction , Precision Medicine , Synthetic Lethal Mutations
2.
Methods Enzymol ; 573: 97-117, 2016.
Article in English | MEDLINE | ID: mdl-27372750

ABSTRACT

Histone chaperones-key actors in the dynamic organization of chromatin-interact with the various histone variants to ensure their transfer in and out of chromatin. In vitro chromatin assembly assays and isolation of protein complexes using tagged histone variants provided first clues concerning their binding specificities and mode of action. Here, we describe an in vivo method using SNAP-tag-based imaging to assess the de novo deposition of histones and the role of histone chaperones. This method exploits cells expressing SNAP-tagged histones combined with individual cell imaging to visualize directly de novo histone deposition in vivo. We show how, by combining this method with siRNA-based depletion, we could assess the function of two distinct histone chaperones. For this, we provide the details of the method as applied in two examples to characterize the function of the histone chaperones CAF-1 and HIRA. In both cases, we document the impact of their depletion on the de novo deposition of the histone variants H3.1 and H3.3, first in a normal context and second in response to DNA damage. We discuss how this cellular assay offers means to define in a systematic manner the function of any chosen chaperone with respect to the deposition of a given histone variant.


Subject(s)
Histone Chaperones/metabolism , Histones/metabolism , O(6)-Methylguanine-DNA Methyltransferase/genetics , Animals , Cell Culture Techniques/methods , Chromatin/metabolism , DNA Damage , Fluorescent Dyes/analysis , Fluorescent Dyes/metabolism , Guanine/analogs & derivatives , Guanine/metabolism , Histone Chaperones/analysis , Histone Chaperones/genetics , Histones/analysis , Histones/genetics , Humans , Microscopy, Fluorescence/methods , Mutation , O(6)-Methylguanine-DNA Methyltransferase/analysis , O(6)-Methylguanine-DNA Methyltransferase/metabolism , Optical Imaging/methods , Recombinant Fusion Proteins/analysis , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
3.
Article in English | MEDLINE | ID: mdl-21209390

ABSTRACT

How a nuclear domain is formed at specific chromatin loci and maintained throughout multiple cellular divisions is a central question in the field of nuclear organization. Recent efforts have concentrated on understanding how a domain is set during development in a particular cell lineage and then how DNA replication and repair in interphase as well as chromosome dynamics in mitosis deal with chromatin states at specific loci to propagate functional organization. In the latter case, for each of these events, one must not only evaluate the impact in terms of the extent of the disruption and/or modification of chromatin but also determine how and when proper organization can be restored thereafter. Using heterochromatin at mouse pericentromeres as a model, we present how important advances have been made that open avenues for understanding mechanisms involved in de novo heterochromatin formation and its duplication during replication.


Subject(s)
Centromere/metabolism , DNA Replication/genetics , Gene Duplication/genetics , Heterochromatin/metabolism , Models, Genetic , Animals , Embryonic Development/genetics , Mice , NIH 3T3 Cells , S Phase
5.
J Cell Sci ; 114(Pt 15): 2711-2, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11683405
6.
J Cell Sci ; 114(Pt 13): 2483-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11559756

ABSTRACT

Phosphorylation of RNA polymerase II largest subunit on its C-terminal domain (CTD) heptapeptide repeats has been shown to play a key role in the regulation of mRNA synthesis and processing. In many higher metazoans, early embryos do not synthesise mRNAs during the first cell cycles following fertilisation. Transcription resumes and becomes an absolute requirement for development after several cell cycles characteristic of each species. Therefore, CTD phosphorylation has been investigated during early development of the African clawed-frog Xenopus laevis. Fertilisation is shown to trigger an abrupt dephosphorylation of the CTD. Phosphorylation of the CTD resumes concurrently with the mid-blastula transition (MBT). Both are advanced with polyspermy and increased temperatures; they do not occur when replication is impaired with aphidicolin. In Xenopus laevis somatic cells, a set of monoclonal antibodies defined distinct phosphoepitopes on the CTD. Two of them were absent before the MBT indicating that the CTD lacks the phosphorylation at the serine-2 position of the heptapeptide. The possible contribution of RNA polymerase II phosphorylation to the developmental-regulation of maternal mRNA processing in embryos is discussed.


Subject(s)
DNA-Directed RNA Polymerases/metabolism , Gene Expression Regulation, Developmental , Xenopus laevis/embryology , Animals , Blastocyst/metabolism , Phosphorylation
7.
J Cell Sci ; 114(Pt 17): 3074, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11590233
8.
Exp Cell Res ; 269(1): 23-34, 2001 Sep 10.
Article in English | MEDLINE | ID: mdl-11525636

ABSTRACT

The nuclear functions in erythrocytes are almost completely extinct. There is no RNA polymerase I transcription, although a remnant nucleolar structure is still present. The remnant nucleolus of Xenopus laevis erythrocytes maintains a morphologically organized structure, nearly exclusively fibrillar. In this inactive nucleolar remnant, we revealed the presence of a modified form of transcription factor UBF. Several proteins of the processing machinery such as fibrillarin, nucleolin and B23/NO38, snoRNAs U3 and U8, and partially processed preribosomal RNAs colocalized in these remnant structures. Attempts to reprogram these erythrocyte nuclei in Xenopus egg extract showed that import of several nucleolar proteins was induced while the nucleolar remnant was disorganized. UBF became abundant and showed a necklace-like distribution on the decondensed ribosomal genes. Fibrillarin, nucleolin, and snoRNAs U3 and U8, also largely imported from the extract, were associated in large prenuclear bodies scattered in the nucleoplasm. B23/NO38 was present in different small bodies formed only in the most decondensed nuclei. In these remodeled erythrocyte nuclei, there was no imported preribosomal RNA and the initial presence of a residual nucleolar structure containing several partners of ribosome biogenesis was not sufficient to promote reassembly of newly imported nucleolar machineries. These nuclei, which reproduce the early events of nucleogenesis are also transcriptionally silent and thus compare to the early embryonic nuclei of Xenopus laevis.


Subject(s)
Cell Extracts/pharmacology , Cell Nucleolus/metabolism , Erythrocytes/metabolism , Oocytes/metabolism , RNA, Ribosomal/biosynthesis , Ribosomes/metabolism , Xenopus laevis/genetics , Animals , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Nucleolus/drug effects , Cell Nucleolus/ultrastructure , Erythrocytes/drug effects , Erythrocytes/ultrastructure , Female , Immunohistochemistry , In Situ Hybridization , Microscopy, Electron , Nuclear Proteins/metabolism , RNA Precursors/metabolism , RNA, Ribosomal/drug effects , RNA, Small Nucleolar/metabolism , Ribosomes/drug effects , Ribosomes/ultrastructure , Transcription, Genetic/drug effects , Transcription, Genetic/physiology , Xenopus laevis/anatomy & histology , Xenopus laevis/metabolism
9.
EMBO J ; 20(12): 3187-96, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11406595

ABSTRACT

Initiation of transcription of protein-encoding genes by RNA polymerase II (Pol II) was thought to require transcription factor TFIID, a complex comprised of the TATA box-binding protein (TBP) and TBP-associated factors (TAF(II)s). In the presence of TBP-free TAF(II) complex (TFTC), initiation of Pol II transcription can occur in the absence of TFIID. TFTC containing the GCN5 acetyltransferase acetylates histone H3 in a nucleosomal context. We have identified a 130 kDa subunit of TFTC (SAP130) that shares homology with the large subunit of UV-damaged DNA-binding factor. TFTC preferentially binds UV-irradiated DNA, UV-damaged DNA inhibits TFTC-mediated Pol II transcription and TFTC is recruited in parallel with the nucleotide excision repair protein XP-A to UV-damaged DNA. TFTC preferentially acetylates histone H3 in nucleosomes assembled on UV-damaged DNA. In agreement with this, strong histone H3 acetylation occurs in intact cells after UV irradiation. These results suggest that the access of DNA repair machinery to lesions within chromatin may be facilitated by TFTC via covalent modification of chromatin. Thus, our experiments reveal a molecular link between DNA damage recognition and chromatin modification.


Subject(s)
DNA Damage , DNA-Binding Proteins/metabolism , Histones/metabolism , Nucleosomes/metabolism , Phosphoproteins/metabolism , RNA-Binding Proteins , Ribonucleoprotein, U2 Small Nuclear/metabolism , Acetylation , Amino Acid Sequence , DNA Repair , DNA-Binding Proteins/genetics , HeLa Cells , Humans , Molecular Sequence Data , RNA Splicing , RNA Splicing Factors , Templates, Genetic , Transcription, Genetic , Ultraviolet Rays , Xeroderma Pigmentosum Group A Protein
10.
EMBO J ; 20(8): 2015-27, 2001 Apr 17.
Article in English | MEDLINE | ID: mdl-11296234

ABSTRACT

To date, the in vivo importance of chromatin assembly factors during development in vertebrates is unknown. Chromatin assembly factor 1 (CAF-1) represents the best biochemically characterized factor promoting chromatin assembly during DNA replication or repair in human cell-free systems. Here, we identify a Xenopus homologue of the largest subunit of CAF-1 (p150). Novel dimerization properties are found conserved in both Xenopus and human p150. A region of 36 amino acids required for p150 dimerization was identified. Deletion of this domain abolishes the ability of p150 to promote chromatin assembly in vitro. A dominant-negative interference based on these dimerization properties occurs both in vitro and in vivo. In the embryo, nuclear organization was severely affected and cell cycle progression was impaired during the rapid early cleaving stages of Xenopus development. We propose that the rapid proliferation at early developmental stages necessitates the unique properties of an assembly factor that can ensure a tight coupling between DNA replication or repair and chromatin assembly.


Subject(s)
Chromatin/metabolism , Chromosomal Proteins, Non-Histone , DNA-Binding Proteins/metabolism , Xenopus/embryology , Amino Acid Sequence , Animals , Binding Sites , Chromatin Assembly Factor-1 , Dimerization , Embryo, Nonmammalian , Evolution, Molecular , Molecular Sequence Data , Nucleosomes/metabolism , Protein Binding , Sequence Homology, Amino Acid , Species Specificity , Transcription Factors , Two-Hybrid System Techniques
11.
Curr Opin Genet Dev ; 11(2): 136-41, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11250135

ABSTRACT

De novo nucleosome assembly coupled to DNA replication and repair in vitro involves the histone chaperone chromatin assembly factor 1 (CAF-1). Recent studies support a model in which CAF-1 can be targeted to newly synthesized DNA through a direct interaction with proliferating cell nuclear antigen (PCNA) and can act synergistically with a newly identified histone chaperone. Insights have also been obtained into mechanisms by which this CAF-1-dependent pathway can establish a repressed chromatin state.


Subject(s)
Chromosomal Proteins, Non-Histone , DNA Replication , DNA/metabolism , Nucleosomes/metabolism , Acetylation , Animals , Chromatin Assembly Factor-1 , DNA Repair , DNA-Binding Proteins/metabolism , Histones/metabolism , Models, Biological , Molecular Chaperones/metabolism , Nucleosomes/chemistry , Proliferating Cell Nuclear Antigen/metabolism
12.
Nat Cell Biol ; 3(2): 114-20, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11175742

ABSTRACT

Histone modifications might act to mark and maintain functional chromatin domains during both interphase and mitosis. Here we show that pericentric heterochromatin in mammalian cells is specifically responsive to prolonged treatment with deacetylase inhibitors. These defined regions relocate at the nuclear periphery and lose their properties of retaining HP1 (heterochromatin protein 1) proteins. Subsequent defects in chromosome segregation arise in mitosis. All these changes can reverse rapidly after drug removal. Our data point to a crucial role of histone underacetylation within pericentric heterochromatin regions for their association with HP1 proteins, their nuclear compartmentalization and their contribution to centromere function.


Subject(s)
Cell Nucleus/drug effects , Centromere/metabolism , Enzyme Inhibitors/pharmacology , Heterochromatin/metabolism , Histone Deacetylase Inhibitors , Histones/metabolism , Hydroxamic Acids/pharmacology , Animals , Blotting, Western , Cell Cycle/drug effects , Cell Cycle/physiology , Cell Line , Cell Nucleus/enzymology , Cell Nucleus/metabolism , DNA/metabolism , Histone Deacetylases/metabolism , Humans , In Situ Hybridization, Fluorescence , Mice , Microscopy, Confocal , Protein Structure, Tertiary , Recombinant Proteins/metabolism
13.
Sci Prog ; 84(Pt 4): 267-90, 2001.
Article in English | MEDLINE | ID: mdl-11838238

ABSTRACT

Recent years have seen significant advances in the characterization and manipulation of individual molecules. The combination of single-molecule fluorescence and micromanipulation enables one to study physical and biological systems at new length scales, to unravel qualitative mechanisms, and to measure kinetic parameters that cannot be addressed by traditional biochemistry. DNA is one of the most studied biomolecules. Imaging single DNA molecules eliminates important limitations of classical techniques and provides a new method for testing polymer dynamics and DNA-protein interactions. Here we review some applications of this new approach to physical and biological problems, focusing on videomicroscopy observations of individual DNA chains extended in a shear flow. We will first describe data obtained on the stretching, relaxation and dynamics of a single tethered polymer in a shear flow, to demonstrate that the deformation of sheared tethered chains is partially governed by the thermally driven fluctuations of the chain transverse to the flow direction. Next, we will show how single-molecule videomicroscopy can be used to study in real time DNA folding into chromatin, a complex association of DNA and proteins responsible for the packaging of DNA in the nucleus of an eukaryotic cell.


Subject(s)
DNA/ultrastructure , Microscopy, Fluorescence , Microscopy, Video , Humans , Polymers , Protein Interaction Mapping
14.
Proc Natl Acad Sci U S A ; 97(26): 14251-6, 2000 Dec 19.
Article in English | MEDLINE | ID: mdl-11114182

ABSTRACT

Fluorescence videomicroscopy and scanning force microscopy were used to follow, in real time, chromatin assembly on individual DNA molecules immersed in cell-free systems competent for physiological chromatin assembly. Within a few seconds, molecules are already compacted into a form exhibiting strong similarities to native chromatin fibers. In these extracts, the compaction rate is more than 100 times faster than expected from standard biochemical assays. Our data provide definite information on the forces involved (a few piconewtons) and on the reaction path. DNA compaction as a function of time revealed unique features of the assembly reaction in these extracts. They imply a sequential process with at least three steps, involving DNA wrapping as the final event. An absolute and quantitative measure of the kinetic parameters of the early steps in chromatin assembly under physiological conditions could thus be obtained.


Subject(s)
Chromatin/metabolism , DNA, Viral/metabolism , Nucleosomes/metabolism , Animals , Bacteriophage lambda/genetics , Cell Extracts , Drosophila , Kinetics , Microscopy, Atomic Force/methods , Microscopy, Video/methods , Models, Molecular , Time Factors , Xenopus
15.
J Cell Sci ; 113 ( Pt 15): 2647-58, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10893180

ABSTRACT

Chromatin is no longer considered to be a static structural framework for packaging DNA within the nucleus but is instead believed to be an interactive component of DNA metabolism. The ordered assembly of chromatin produces a nucleoprotein template capable of epigenetically regulating the expression and maintenance of the genome. Factors have been isolated from cell extracts that stimulate early steps in chromatin assembly in vitro. The function of one such factor, chromatin-assembly factor 1 (CAF-1), might extend beyond simply facilitating the progression through an individual assembly reaction to its active participation in a marking system. This marking system could be exploited at the crossroads of DNA replication and repair to monitor genome integrity and to define particular epigenetic states.


Subject(s)
Chromatin/genetics , Chromatin/metabolism , Chromosomal Proteins, Non-Histone , DNA Repair/physiology , DNA Replication/physiology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Animals , Chromatin Assembly Factor-1
16.
J Cell Biol ; 149(2): 293-306, 2000 Apr 17.
Article in English | MEDLINE | ID: mdl-10769023

ABSTRACT

Transcription and splicing of messenger RNAs are temporally and spatially coordinated through the recruitment by RNA polymerase II of processing factors. We questioned whether RNA polymerase I plays a role in the recruitment of the ribosomal RNA (rRNA) processing machinery. During Xenopus laevis embryogenesis, recruitment of the rRNA processing machinery to the nucleolar domain occurs in two steps: two types of precursor structures called prenucleolar bodies (PNBs) form independently throughout the nucleoplasm; and components of PNBs I (fibrillarin, nucleolin, and the U3 and U8 small nucleolar RNAs) fuse to the nucleolar domain before components of PNBs II (B23/NO38). This fusion process is independent of RNA polymerase I activity, as shown by actinomycin D treatment of embryos and by the lack of detectable RNA polymerase I at ribosomal gene loci during fusion. Instead, this process is concomitant with the targeting of maternally derived pre-rRNAs to the nucleolar domain. Absence of fusion was correlated with absence of these pre-rRNAs in nuclei where RNA polymerase II and III are inhibited. Therefore, during X. laevis embryogenesis, the recruitment of the rRNA processing machinery to the nucleolar domain could be dependent on the presence of pre-rRNAs, but is independent of either zygotic RNA polymerase I transcription or the presence of RNA polymerase I itself.


Subject(s)
Cell Nucleolus/physiology , Embryo, Nonmammalian/physiology , Gene Expression Regulation, Developmental/physiology , Oocytes/physiology , RNA, Ribosomal/genetics , RNA, Small Nuclear/metabolism , Transcription, Genetic/physiology , Xenopus laevis/embryology , Animals , Blastocyst/physiology , Cell Nucleolus/ultrastructure , Chromosomal Proteins, Non-Histone/metabolism , Dactinomycin/pharmacology , Female , Gastrula/physiology , In Situ Hybridization, Fluorescence , Nuclear Envelope/physiology , Nuclear Envelope/ultrastructure , Phosphoproteins/metabolism , RNA Precursors/genetics , RNA Precursors/metabolism , RNA, Small Nuclear/genetics , RNA-Binding Proteins/metabolism , Transcription, Genetic/drug effects , Nucleolin
17.
Exp Cell Res ; 256(2): 392-9, 2000 May 01.
Article in English | MEDLINE | ID: mdl-10772812

ABSTRACT

Xenopus is a well-characterized model system for the investigation of biological processes at the molecular, cellular, and developmental level. The successful application of a rapid and reliable method for transgenic approaches in Xenopus has led to renewed interest in this system. We have explored the applicability of tetracycline-regulated gene expression, first described by Gossen and Bujard in 1992, to the Xenopus system. By optimizing conditions, tetracycline repressor induced expression of a luciferase reporter gene was readily and reproducibly achieved in both the Xenopus oocyte and developing embryo. This high level of expression was effectively abrogated by addition of low levels of tetracycline. The significance of this newly defined system for studies of chromatin dynamics and developmental processes is discussed.


Subject(s)
Carrier Proteins , Gene Expression Regulation , Oocytes/metabolism , Tetracycline/pharmacology , Animals , Bacterial Proteins/genetics , Chromatin/metabolism , Embryo, Nonmammalian , Genes, Reporter , Herpes Simplex Virus Protein Vmw65/genetics , In Vitro Techniques , Luciferases/biosynthesis , Luciferases/genetics , Repressor Proteins/genetics , Xenopus
18.
EMBO J ; 19(5): 1023-33, 2000 Mar 01.
Article in English | MEDLINE | ID: mdl-10698943

ABSTRACT

The mouse mammary tumor virus (MMTV) promoter is induced by glucocorticoid hormone. A robust hormone- and receptor-dependent activation could be reproduced in Xenopus laevis oocytes. The homogeneous response in this system allowed a detailed analysis of the transition in chromatin structure following hormone activation. This revealed two novel findings: hormone activation led to the establishment of specific translational positioning of nucleosomes despite the lack of significant positioning in the inactive state; and, in the active promoter, a subnucleosomal particle encompassing the glucocorticoid receptor (GR)-binding region was detected. The presence of only a single GR-binding site was sufficient for the structural transition to occur. Both basal promoter elements and ongoing transcription were dispensable. These data reveal a stepwise process in the transcriptional activation by glucocorticoid hormone.


Subject(s)
Glucocorticoids/genetics , Mammary Tumor Virus, Mouse/genetics , Nucleosomes/genetics , Animals , Female , Gene Expression Regulation , Glucocorticoids/metabolism , Mice , Nucleosomes/metabolism , Oocytes , Promoter Regions, Genetic , Xenopus laevis
19.
Mol Cell Biol ; 20(4): 1206-18, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10648606

ABSTRACT

Sensing DNA damage is crucial for the maintenance of genomic integrity and cell cycle progression. The participation of chromatin in these events is becoming of increasing interest. We show that the presence of single-strand breaks and gaps, formed either directly or during DNA damage processing, can trigger the propagation of nucleosomal arrays. This nucleosome assembly pathway involves the histone chaperone chromatin assembly factor 1 (CAF-1). The largest subunit (p150) of this factor interacts directly with proliferating cell nuclear antigen (PCNA), and critical regions for this interaction on both proteins have been mapped. To isolate proteins specifically recruited during DNA repair, damaged DNA linked to magnetic beads was used. The binding of both PCNA and CAF-1 to this damaged DNA was dependent on the number of DNA lesions and required ATP. Chromatin assembly linked to the repair of single-strand breaks was disrupted by depletion of PCNA from a cell-free system. This defect was rescued by complementation with recombinant PCNA, arguing for role of PCNA in mediating chromatin assembly linked to DNA repair. We discuss the importance of the PCNA-CAF-1 interaction in the context of DNA damage processing and checkpoint control.


Subject(s)
Chromatin/metabolism , Chromosomal Proteins, Non-Histone , DNA Damage , DNA-Binding Proteins/metabolism , Proliferating Cell Nuclear Antigen/metabolism , Animals , Base Sequence , Binding Sites/genetics , Cell-Free System , Chromatin/genetics , Chromatin Assembly Factor-1 , DNA/biosynthesis , DNA Primers/genetics , DNA Repair , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Drosophila , HeLa Cells , Humans , In Vitro Techniques , Models, Biological , Models, Molecular , Nucleosomes/metabolism , Proliferating Cell Nuclear Antigen/genetics , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transcription Factors
20.
J Cell Biol ; 147(6): 1153-66, 1999 Dec 13.
Article in English | MEDLINE | ID: mdl-10601331

ABSTRACT

To investigate the mechanisms that assure the maintenance of heterochromatin regions, we took advantage of the fact that clusters of heterochromatin DNA replicate late in S phase and are processed in discrete foci with a characteristic nuclear distribution. At the light microscopy level, within these entities, we followed DNA synthesis, histone H4 acetylation, heterochromatin protein 1 (Hp1alpha and -beta), and chromatin assembly factor 1 (CAF-1). During replication, Hp1alpha and -beta domains of concentration are stably maintained, whereas heterochromatin regions are enriched in both CAF-1 and replication-specific acetylated isoforms of histone H4 (H4Ac 5 and 12). We defined a time window of 20 min for the maintenance of this state. Furthermore, treatment with Trichostatin A (TSA), during and after replication, sustains the H4Ac 5 and 12 state in heterochromatin excluding H4Ac 8 and 16. In comparison, early replication foci, at the same level, did not display any specific enrichment in H4Ac 5 and 12. These data emphasize the specific importance for heterochromatin of the replication-associated H4 isoforms. We propose that perpetuation of heterochromatin involves self-maintenance factors, including local concentration of Hp1alpha and -beta, and that a degree of plasticity is provided by the cycle of H4 acetylation/deacetylation assisted by CAF-1.


Subject(s)
DNA Replication , Heterochromatin/genetics , Heterochromatin/metabolism , Acetylation/drug effects , Animals , Cell Line , Chromatin Assembly Factor-1 , Chromobox Protein Homolog 5 , Chromosomal Proteins, Non-Histone/metabolism , DNA/biosynthesis , DNA/genetics , DNA Replication/genetics , DNA-Binding Proteins/metabolism , Fluorescent Antibody Technique , HeLa Cells , Heterochromatin/chemistry , Histone Deacetylase Inhibitors , Histone Deacetylases/metabolism , Histones/metabolism , Humans , Hydroxamic Acids/pharmacology , Mice , Protein Isoforms/metabolism , S Phase/genetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...